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Summary A set of growth arrest-specific (gas) genes negatively regulated by serum has been identified. We
report the analysis of the expression of one of them (gas-i) in transformed cells. We found a down regulation
of gas-I expression in NIH 3T3 cells transfected in vitro with an activated Ha-ras oncogene. In five
chemically-induced mouse tumours grown in vivo the amounts of gas-I mRNA were largely different but not
related to the proliferating activity (evaluated by both H3 histone expression and 3H-thymidine incorporation
into DNA). The amount of gas-I mRNA in the tumours was in general higher than in normal tissues.
Expression of c-myc was also evaluated and found to be high in tumours which exhibited low gas-I expression.
Two fibrosarcomas, CA-2 and CB-20, with similar phenotype, similar growth rate, different expression of
c-myc and 100-fold difference in gas-I expression were further investigated and gas-I expression was found to
be correlated with the expression of a differentiated function (as judged from collagen expression). Cell lines
derived from CA-2 and CB-20 and maintained under different culture conditions showed that the cell cycle
regulation and serum response of gas-I expression were lost in CA-2. The higher steady state level of gas-I
mRNA in spite of a shorter mRNA half life suggests that in CB-20 cells the gas-I gene is transcribed faster
than in CA-2 cells indicating that transcriptional regulation is the major determinant of gas-I gene expression
in tumour cells. The finding of gas-I expression in tumour cells suggests that its expression is not sufficient to
maintain cells into quiescence, however, as a marker specific for the Go phase, it could be useful, in
conjunction with other growth related genes, to define the cell cycle distribution of a cell population.
Cellular proliferation in eukaryotes is a highly controlled and
complex process involving expression of several genes
(Baserga, 1985). Cancer can be seen as an unregulated
growth of cells which have escaped intra and extra cellular
controls; many regulatory steps of cell proliferation have
been shown to be defective in cancer cells (Pardee, 1989).
One of the pivotal points in cell proliferation is the transition
from the quiescent state, called Go, to the GI phase, in which
the chain of molecular events leading to cell duplication is
initiated (Pardee, 1989). Many studies have been focused on
the identification of genes induced by mitogenic factors dur-
ing the Go to GI transition (see Herschman, 1989 for review).
The finding of several oncogenes among the genes early
induced after mitogenic stimulation of cells (Kaczamarek,
1986) has been important in understanding the alterations of
cell growth control that occur in cancer cells. However, the
recent isolation of growth inhibitory genes has reinforced the
idea that control of cell proliferation is achieved through an
interplay of inducing and represssing molecules which deter-
mine the balance between regulated growth and cancer
(Horowitz et al., 1988). In addition to these growth
inhibitory genes, a number of genes expressed specifically
during the quiescent state have been isolated (Schneider et
al., 1988; Bedard et al., 1989; Fornace et al., 1989; Kallin et
al., 1991). The gas (growth arrest-specific) genes were
identified by subtraction hybridisation on the basis of
preferential expression in the Go phase of the cycle
(Schneider et al., 1988). One of these genes, gas-1, maps on
mouse chromosome 13 (Colombo et al., 1992), and is nega-
tively regulated by serum at the transcriptional level (Cicca-
relli et al., 1990). Since cancer cells provide valuable tests of
the physiological importance in proliferative control of pro-
posed growth-regulated or growth-regulatory genes, we stud-
ied gas-I expression in chemically-induced tumours in vivo, in
cell lines derived from these tumours and grown under differ-
ent culture conditions and in oncogene transformed NIH 3T3
cells and fibroblasts.
Materials and methods
Cell lines and tumours
Normal and Ha-ras transformed NIH 3T3 cells were obtain-
ed from Dr M. Pierotti (I.N.T., Milan). Serum starvation
and refeeding experiments were performed as previously des-
cribed (Schneider et al., 1988).
C-26 is a murine colon adenocarcinoma induced in BALB/
c mice by N-nitroso-N-methylurethan. CA-2, CB-20 and DB-
1/-3 are fibrosarcomas and rabdomyosarcomas, respectively,
induced in our laboratory by subcutaneous injection of
100 mg methylcholanthrene into BALB/c, (BALB/c x C57
BL/6)F1 and DBA/2 mice, respectively. Tumours were main-
tained in vivo by subcutaneous passages in syngeneic mice.
Cell lines from CA-2 and CB-20 fibrosarcomas were obtained
by trypsinisation of tumour nodules collected from tumour
bearing mice and established for in vitro growth in MEM
(GIBCO, Paisley, UK) plus 10% FBS (GIBCO).
Northern blot analysis
Total cellular RNA, extracted from cell cultures, mouse
tissues or 400 mm3 tumours according to Chomczynski and
Sacchi (1987) was run in 20pg aliquots on 1.2% agarose/
formaldehyde gels, blotted to Hybond C extra filters (Amer-
sham), which were than baked for 2 h at 80°C and prehybri-
dised at 42°C for 6 h in 50% formamide, 5 x SSC, 50 mM
sodium phosphate pH 6.5, 1 x Denhardt's solution, 100 fg
ml-' denatured ssDNA. Hybridisations were done in the
same solution with 2-3 x 106c.p.m. ml-' of probe for 20 h
at 42'C. The DNA probes were gel-purified inserts labelled
with 32P dCTP using a Nick translation kit (Amersham).
After hybridisation filters were washed at a final stringency
of 0.1 x SSC, 0.1% SDS at 42'C and exposed to autoradio-
graphy. For quantitative determinations autoradiograms
were scanned with a laser densitometer (LKB) making sure
that the exposure was in the linear range. The values were
calculated by normalising to the signal of the GAPDH con-
trol probe.
Determination ofDNA synthesis
DNA synthesis in vivo was determined by analysis of 3H-
thymidine incorporation into DNA. Solid tumour fragments
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of about 1 mm3 were transplanted subcutaneously with a
trocar into anesthetised syngeneic mice. When the tumours
reached the volume of 400 mm3, mice were given a single i.p.
injection (10 jiCi/mouse) of methyl-3H-thymidine (sp. act.
70 Ci mmol-') 1 h prior to sacrifice. At the time of tumour
excision, 11 - 12 days after transplant, all nodules were
actively growing and did not show signs of necrosis. The
tumours were homogenised in 6 volumes of 0.075 M NaCl,
0.025M EDTA pH 7.6 and nucleic acids precipitated by
adding an equal volume of ice cold 2 N perchloric acid
(PCA). Pellets were washed three times with ice-cold 0.5 N
PCA and DNA was extracted with 0.5 N PCA for 1 h at
700C. Aliquots of the extract were taken for measurement of
radioactivity and for determination of the DNA content by
the diphenylamine method (Burton, 1956).
Probes
The probes used were: the mouse gas-I cDNA (Schneider et
al., 1988); the pc54 cDNA for mouse c-myc (Stanton et al.,
1983); the human H3 histone probe pFo422 (Hirschhorn et
al., 1984); the p2R2 cDNA for rat a2 (I) procollagen (Geno-
vese et al., 1984) and the pHcGAP clone for GAPDH (Tso et
al., 1985).
Results
gas-i expression in ras-transformed cells
As a first attempt to study the effect of oncogenic transfor-
mation on the expression of the gas-I gene, we examined
gas-I mRNA levels in NIH 3T3 cells transformed with the
Ha-ras oncogene. The Northern blot reported in Figure 1
shows, in the first three lanes, the typical changes of gas-I
expression during the cell cycle in NIH 3T3 cells: gas-I
mRNA accumulated in serum starved cells and disappeared
after serum stimulation (Schneider et al., 1988). In cells
containing the activated oncogene gas-I expression was lower
than in their untransfected counterpart, in fact the level of
gas-I mRNA in ras-transformed cells, grown in 10% serum,
was the same as that of normal NIH 3T3 cells restimulated
to grow by serum addition (compare lane four with lane
three in Figure 1). As a control, the same filter was rehyb-
ridised with a probe for GAPDH mRNA which remains
constant throughout the cell cycle (Manfioletti et al., 1990).
Essentially the same results were obtained using K-ras trans-
formed BALB/c fibroblasts (data not shown).
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Figure 1 Northern blot analysis of gas-I mRNA levels in nor-
mal and Ha-ras transformed NIH 3T3 cells. Lane 1: RNA from
NIH 3T3 cells grown in 10% foetal calf serum (FCS); lane 2:
RNA from NIH 3T3 cells kept in 0.5% FCS for 24 h; lane 3:
RNA from NIH 3T3 cells kept in 0.5% FCS for 24 h and
restimulated with 20% FCS for 6 h; lane 4: RNA from Ha-ras
transformed NIH 3T3 cells grown in 10% FCS. The blot was
stripped and reprobed with the GAPDH cDNA.
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gas I expression in chemically-induced mouse tumours
To assess whether the down regulation of the gas-I gene in
transformed cells occurred also in vivo, several chemically-
induced mouse tumours grown subcutaneously in syngeneic
mice were investigated for the expression of the gas-I gene.
The Northern blot of Figure 2 shows an example of the large
differences in the amount of gas-I mRNA among the
tumours examined. Densitometric quantifications are report-
ed in Table I. It should be noted that gas-I expression was in
general higher in tumours than in lung or muscle, which have
been previously described as tissues with the highest expres-
sion of this gene (Schneider et al., 1988). The tumours were
also analysed for the expression of some cell cycle related
genes (Figure 2). Expression of the histone H3 gene, which
parallels the percentage of cells that incorporate 3H-thymi
dine (Jaskulski et al., 1988, Heintz, 1991), was approximately
the same in all the tumours (Table I). On the contrary, the
amount of c-myc mRNA, which is maximally expressed in
early GI (Norman et al., 1988) was variable, i.e. high in
DB-3, C-26 and CA-2, low in CB-20 and DB-1. Both histone
H3 and c-myc mRNAs were almost undetectable in the
normal tissues. Hybridisation with the GAPDH probe dem-
onstrated similar loading of RNA in each lane of the gel.
Furthermore, we estimated the proliferating activity of our
tumours in vivo by measuring 3H-thymidine incorporation
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Figure 2 Northern blot analysis of RNA from mouse tissues and
in vivo-grown tumours hybridised with the indicated probes. Lane
1: C-26 colon carcinomas; lane 2: DB-1 rabdomyosarcoma; lane
3: CA-2 fibrosarcoma; lane 4: DB-3 rabdomyosarcoma; lane 5:
CB-20 fibrosarcoma; lane 6: Lung; lane 7: Muscle.
into DNA. Figure 3 shows that DNA synthesis did not vary
by more than 2-fold for the various samples. This result,
which was in agreement with the one obtained by analysis of
H3 histone gene expression, indicated that the growth rates
of the tumours did not differ greatly. CB-20 and CA-2, two
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Table I gas-I, c-myc and histone H3 mRNA expression in tumours
grown in vivo
gas-i c-myc H3
CB-20 Iooa 100 100
CA-2 1 500 155
C-26 400 280 185
DB-1 65 30 100
DB-3 35 160 80
aArbitrary densitometric units.
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Figure 3 DNA synthesis in tumours growing in vivo as evaluated
by 3H-thymidine incorporation. Results are given as mean of
c.p.m. mg- I DNA ±s.d.; n = 6.
methylcholanthrene-induced fibrosarcomas showing similar
growth rate, different expression of c-myc and a great differ-
ence in gas-I expression (Table I) were investigated more in
detail.
We compared the degree of differentiation of these
tumours. The Northern blot in Figure 4 shows that collagen
mRNA levels were much higher in the CB-20 than in the
CA-2 tumour indicating that in these two fibrosarcomas
there is good correlation between expression of a differ-
entiated function and the levels of gas-I mRNA. Reprobing
with the GAPDH cDNA showed that equal amounts of
RNA for both samples were loaded into the gel.
Level ofgas-i mRNA under different growth conditions
In order to analyse whether or not the gas-I gene maintained
its distinctive cell cycle-related behaviour in CB-20 and CA-2
cells, gas-I and c-myc mRNAs were analysed in cell lines
derived from the two fibrosarcomas and maintained under
different culture conditions. The Northern blot of Figure 5
shows that the transition from in vivo growth to in vitro
culture changed the pattern of gas-I expression of the two
tumours. In fact, when tumour cells were grown in vitro in
10% serum, a 10 fold increase and a 10 fold reduction in
gas-I mRNA levels in CA-2 and CB-20 cells occurred,
respectively. The end result of in vitro growth was therefore
the abolition of the differences of gas-1 expression observed
in vivo. When CB-20 cells were refed with 20% serum after
36 h of starvation the level of gas-I mRNA was modulated
in a way analogous to that occurring in NIH 3T3 cells (see
Figure 1). On the contrary, the amount of gas-I mRNA in
the CA-2 cells was only partially affected by starvation and
serum refeeding, and remained at a relatively constant level,
higher than in the in vivo-growing tumour (Figure 5). Hyb-
ridisation with the c-myc probe indicated that, in the CB-20
GAPDH -1.4
Figure 4 Northern blot analysis ofpro-a2 (I) collagen expression
in in vivo-grown fibrosarcomas. Lane 1: CB-20 fibrosarcoma; lane
2: CA-2 fibrosarcoma. The same filter was stripped and hybrid-
ised with the GAPDH probe.
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Figure 5 Northern blot analysis of gas-l, c-myc and GAPDH
mRNA levels in CB-20 and CA-2 tumours in vivo and in vitro.
Lanes 1-4: CB-20 tumour; lane 5-8: CA-2 tumour. Lanes I and
5: tumour grown in vivo; lanes 2 and 6: cells grown in vitro with
10% FCS; lanes 3 and 7: cells grown in vitro starved for 36 h in
0.5% FCS; lanes 4 and 8: cells grown in vitro, starved for 36 h in
0.5% FCS and restimulated with 20% FCS for 6 h.
cell line, the level of c-myc mRNA increased after adaptation
to in vitro culture and varied according to the cell cycle
phases, whereas in the CA-2 tumour c-myc expression was
repressed during transition from in vivo to in vitro growth
condition and the changes in response to the various culture
conditions were less evident. The GAPDH mRNA, which is
known to be constitutively expressed in resting and pro-
liferating cells (Manfioletti et al., 1990), was constant in all
the samples.
Analysis ofgas-i mRNA turnover in CB-20 and CA-2 cell
lines
The differences of gas-I expression between CB-20 and CA-2
cells could be due to different transcription rates or to post-
transcriptional events; we evaluated the turnover of the gas-I
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mRNA in serum-deprived CA-2 and CB-20 cells. In this
culture condition, in fact, the two cell lines present the
greatest differences in the steady state level of gas-I mRNA.
Starved cells of the CB-20 and CA-2 lines were treated with
Actinomycin D to block new mRNA synthesis and then
harvested for RNA extraction after 2 and 6h. Figure 6
shows the decay kinetic of the gas-I mRNA: 2 h after addi-
tion of the drug the level of gas-I mRNA in CB-20 cells was
reduced to one half the value of untreated cells, indicating a
half life of about 2 h which was similar to that reported for
quiescent NIH 3T3 cells (Ciccarelli et al., 1990). In the CA-2
cells gas-I mRNA seems to have a slower decay than in the
CB-20 tumour, in fact at 2 h its level was only slightly
decreased and disappeared later on (6 h). We confirm that
the expression of GAPDH gene was unaffected by exposure
to Actinomycin D (Ciccarelli et al., 1990).
Discussion
In cancer cells the control of proliferation is defective and
many alterations in processes occurring during the Go to GI
transition have been described in tumours. The availability of
a molecular probe for one of the genes which are specifically
expressed in quiescent cultured cells and which are repressed
when cells re-enter the cell cycle (Schneider et al., 1988)
prompted us to analyse gas-I expression in transformed cells
both in vitro and in vivo.
We report that transformation of NIH 3T3 cells with an
activated Ha-ras oncogene down regulates gas-I expression.
Similar results were obtained using K-ras to transfect both
NIH 3T3 cells (Ciccarelli et al., 1990) and primary mouse
fibroblasts (data not shown). The lower expression of the
gas-I gene in the in vitro transformed cells is consistent with
its definition of growth arrest-specific gene.
However, high level expression of gas-i in most of the
rapidly proliferating tumours in vivo seems less consistent
with growth arrest-specific expression. Moreover, the finding
of very different levels of gas-I mRNA in tumours with
similar growth rates indicates that the expression of gas-i is
not strictly related to the proliferating activity of the cells.
Comparison with the level of expression of other growth
regulated genes allowed a better understanding of the charac-
teristic of gas-I gene expression in tumours. In fact, even
though parallel expression of c-myc and histone genes is
considered an indicator of active cell growth (Dike &
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Figure 6 Turnover of gas-I mRNA in CB-20 and CA-2 cells
under growth arrest conditions. Cells were kept for 36 h in 0.5%
FCS (lanes 1 and 4), treated with 5 Lg ml-' of Actinomycin D
and harvested after 2 (lanes 2 and 5) or 6 h (lanes 3 and 6). Lanes
1-3: CB-20 cells; lanes 4-6: CA-2 cells. The filter was succes-
sively rehybridised with the GAPDH probe.
Farmer, 1988), in most of our tumour samples the expression
of these genes does not seem to be coordinated: CB-20 and
CA-2 tumours, for example, have a small difference (0.5 fold)
in the level of histone mRNA (see Table I) suggesting that
these tumours have a similar fraction of cells in S phase (as
also confirmed by determination of thymidine incorporation).
However, c-myc expression was strikingly different as the
amount of c-myc mRNA in CA-2 was 5-fold higher than in
CB-20. The latter tumour, on the other hand, had a much
greater expression of gas-I that resulted as being inversely
related to c-myc (compare lane 3 with lane 5 in Figure 2).
Since the expression of certain growth regulated genes seems
to be a reliable criterion to discriminate between Go and GI
(Baserga, 1989) and considering c-myc and gas-i as markers
of the GI and Go phases, respectively (Norman et al., 1988;
Schneider etal., 1988), CA-2 and CB-20 display diametrically
opposed fractions of cells in Go and GI. The availability of a
probe specific for the Go phase seems to be useful to distin-
guish cycling from non cycling cells allowing to better define
the cell cycle distribution in tissues, particularly tumours,
collected in vivo.
It is generally accepted that differentiated functions are
expressed in quiescent cells; the finding that CB-20, in addi-
tion to a greater expression of gas-i, has higher levels of
collagen mRNA than CA-2 is consistent with the interpreta-
tion that CB-20 has a fraction ofcells in the Go phase greater
than CA-2. Histological analysis did not reveal big differ-
ences between the two fibrosarcomas (data not shown).
Diversities in functional (expression of collagen and response
to serum starvation) more than morphological differentiation
could be explained by the different fractions of cells in the Go
and GI phases. The greater expression of gas-I gene in
tumours compared to that in normal tissues could find
explanation by considering that the accumulation of gas-I
mRNA occurs only in cells which, being in Go, still conserve
the ability to be recruited into active proliferation. Con-
sistently, cells in normal tissues, which irreversibly have left
the cell cycle, poorly express this gene. Experimental support
for this interpretation came from Friend's erithroleukaemia
cells induced to differentiate with hemin; these cells show
high levels ofgas-5 mRNA which decreased only after treat-
ment with DMSO, which is able to induce terminal differen-
tation (Coccia etal., 1989). Moreover, another gene, induced
by growth cessation signals, presents a low level of expression
in differentiated tissues in vivo (Fornace et al., 1989).
Malignant transformation is often associated with loss of
growth control; analysis of gas-I expression in cells, grown
under different culture conditions, showed that cell cycle
regulation and serum response of this gene were lost in
ras-transformed NIH 3T3 cells and in CA-2. However the
finding that in the CB-20 cells the expression of the gas-I
gene is still modulated by serum, throughout the cell cycle,
indicates that certain regulatory mechanisms are not always
lost in transformed cells. The changes of gas-I gene expres-
sion occurring after transition from in vivo to in vitro growth
could result from the selection of cells which differently
express gas-I or from some regulative effects of the tumour
stroma occurring in vivo and lost in vitro (Singh et al., 1992).
Previous reports showed that in NIH 3T3 cells gas-i gene
expression is controlled by serum at the transcriptional level
(Ciccarelli etal., 1990). Analysis ofgas-I mRNA turnover, in
our fibrosarcoma cell lines, showed that this mRNA is less
stable in the CB-20 than in the CA-2. However, the steady-
state level ofgas-I mRNA is much higher in the CB-20, and
therefore in this tumour the gas-I gene should be transcribed
faster. This result, while demonstrating the existence of varia-
tions in gas-I mRNA stability, in different tumours, indicated
that, as in NIH 3T3, the rate of transcription seems to be the
major determinant of gas-I gene expression.
The function of the gas-I gene product has not been
established yet and therefore its role, if any, in the chain of
events required for the maintenance of controlled growth is
still obscure; from our data, we can only conclude that gas-I
appears insufficient to drive cells into quiescence, thus mak-
ing unlikely its possible use to revert the tumorigenic pheno-gas-I EXPRESSION IN TUMOURS 31
type by gene transfer. However, as a marker for the Go
phase, gas-I could be useful to analyse the distribution of
cellular populations in the different phases of the cycle,
notably between Go and GI, the two phases where the control
of cell proliferation occurs. Analysis of gas-I expression
could be particularly valuable in vivo and in those cases
where histone and c-myc, the two genes usually considered
markers of cellular growth rate (Dike & Farmer, 1988),
behave differently.
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